Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (4791)	11/20/1997 2:29:00 PM
From: Pseudo Biologist	Respond to of 17367

George, thanks for the note. I am not sure what you feel bad about or what "backfired." My Giroir story seems pretty much the same as yours, as far as I can tell. I think the issue of the "sins of the past (management)" helps understand a point you've made many times here, namely the lack of coverage and/or support from major brokerage houses. It does not help that the conditions BPI is supposed to treat share some features with sepsis, and you know that's a dirty word in biotech investment (cf. Synergen, Celltech/Bayer anti-TNF, etc). I think this very point has been made here re. Sturza or some other guru. PB